Chordia Therapeutics Inc. (JP:190A) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Chordia Therapeutics Inc. is committed to launching innovative drugs with novel mechanisms of action, aiming for sustainable sales and growth. The company emphasizes strong corporate governance to enhance trust and adapt to changing business environments, with Takeda Pharmaceutical Company Limited as its largest shareholder. Despite being a small player in the pharmaceutical sector, Chordia is listed on the Growth Market and is focused on strengthening its organizational structure for long-term success.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.